Meera Natarajan

Array ( [id] => 5743574 [patent_doc_number] => 20060089299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Selective treatment of endothelial somatostatin receptors' [patent_app_type] => utility [patent_app_number] => 11/189597 [patent_app_country] => US [patent_app_date] => 2005-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8593 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089299.pdf [firstpage_image] =>[orig_patent_app_number] => 11189597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 82637 [patent_doc_number] => 07740846 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Inhibitors of angiopoietin-like 4 protein, combinations, and their use' [patent_app_type] => utility [patent_app_number] => 11/185215 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 25 [patent_no_of_words] => 37763 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/740/07740846.pdf [firstpage_image] =>[orig_patent_app_number] => 11185215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4651011 [patent_doc_number] => 20080038267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Treatment Of Cancer' [patent_app_type] => utility [patent_app_number] => 11/630936 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12647 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038267.pdf [firstpage_image] =>[orig_patent_app_number] => 11630936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5642279 [patent_doc_number] => 20060280734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Retargeting' [patent_app_type] => utility [patent_app_number] => 11/165672 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18739 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20060280734.pdf [firstpage_image] =>[orig_patent_app_number] => 11165672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5814026 [patent_doc_number] => 20060084123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'MN and hypoxia' [patent_app_type] => utility [patent_app_number] => 11/166997 [patent_app_country] => US [patent_app_date] => 2005-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 31378 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084123.pdf [firstpage_image] =>[orig_patent_app_number] => 11166997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6925796 [patent_doc_number] => 20050239051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Use of isogenic human cancer cells for high-throughput screening and drug discovery' [patent_app_type] => utility [patent_app_number] => 11/159229 [patent_app_country] => US [patent_app_date] => 2005-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8027 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20050239051.pdf [firstpage_image] =>[orig_patent_app_number] => 11159229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 907697 [patent_doc_number] => 07332585 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-19 [patent_title] => 'Bispecific single chain Fv antibody molecules and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/154103 [patent_app_country] => US [patent_app_date] => 2005-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 22877 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/332/07332585.pdf [firstpage_image] =>[orig_patent_app_number] => 11154103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4669376 [patent_doc_number] => 20080044436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Method for Screening and Compositions for Treating Cancers' [patent_app_type] => utility [patent_app_number] => 11/597633 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21765 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044436.pdf [firstpage_image] =>[orig_patent_app_number] => 11597633 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5590878 [patent_doc_number] => 20060040330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Method of cancer screening' [patent_app_type] => utility [patent_app_number] => 11/138334 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8572 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040330.pdf [firstpage_image] =>[orig_patent_app_number] => 11138334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 810370 [patent_doc_number] => 07417127 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-08-26 [patent_title] => 'Antibodies specific for CD44v6' [patent_app_type] => utility [patent_app_number] => 11/136538 [patent_app_country] => US [patent_app_date] => 2005-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 39278 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/417/07417127.pdf [firstpage_image] =>[orig_patent_app_number] => 11136538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6931166 [patent_doc_number] => 20050282201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'Cell-based detection and differentiation of lung cancer' [patent_app_type] => utility [patent_app_number] => 11/131324 [patent_app_country] => US [patent_app_date] => 2005-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 48481 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282201.pdf [firstpage_image] =>[orig_patent_app_number] => 11131324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 256503 [patent_doc_number] => 07576178 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-18 [patent_title] => 'DADD, death activator death domain protein' [patent_app_type] => utility [patent_app_number] => 11/129648 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7044 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/576/07576178.pdf [firstpage_image] =>[orig_patent_app_number] => 11129648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6978774 [patent_doc_number] => 20050288492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Anti-activated RAS antibodies' [patent_app_type] => utility [patent_app_number] => 11/127903 [patent_app_country] => US [patent_app_date] => 2005-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 27485 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288492.pdf [firstpage_image] =>[orig_patent_app_number] => 11127903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7247399 [patent_doc_number] => 20050272107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Intracellular antibodies' [patent_app_type] => utility [patent_app_number] => 11/127677 [patent_app_country] => US [patent_app_date] => 2005-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18251 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272107.pdf [firstpage_image] =>[orig_patent_app_number] => 11127677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4898895 [patent_doc_number] => 20080118509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Monoclonal Antibody Sc104 and Derivative Thereof Specifically Binding to a Sialyltetraosyl Carbohydrate as a Potential Anti-Tumor Therapeutic Agent' [patent_app_type] => utility [patent_app_number] => 11/596501 [patent_app_country] => US [patent_app_date] => 2005-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 18326 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20080118509.pdf [firstpage_image] =>[orig_patent_app_number] => 11596501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6958478 [patent_doc_number] => 20050214848 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Reagents and methods useful for detecting diseases of the breast' [patent_app_type] => utility [patent_app_number] => 11/126456 [patent_app_country] => US [patent_app_date] => 2005-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 36435 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20050214848.pdf [firstpage_image] =>[orig_patent_app_number] => 11126456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5766755 [patent_doc_number] => 20060018895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/126798 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 48361 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018895.pdf [firstpage_image] =>[orig_patent_app_number] => 11126798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5625282 [patent_doc_number] => 20060263787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Immunoglobulin-like variable chain binding polypeptides and methods of use' [patent_app_type] => utility [patent_app_number] => 11/126105 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14458 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20060263787.pdf [firstpage_image] =>[orig_patent_app_number] => 11126105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5820453 [patent_doc_number] => 20060024766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Bifunctional molecules' [patent_app_type] => utility [patent_app_number] => 11/123696 [patent_app_country] => US [patent_app_date] => 2005-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13882 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024766.pdf [firstpage_image] =>[orig_patent_app_number] => 11123696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6977424 [patent_doc_number] => 20050287140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Antibodies to angiogenesis inhibiting domains of CD148' [patent_app_type] => utility [patent_app_number] => 11/112240 [patent_app_country] => US [patent_app_date] => 2005-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15359 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287140.pdf [firstpage_image] =>[orig_patent_app_number] => 11112240 [rel_patent_id] =>[rel_patent_doc_number] =>)